Suchergebnisse — DigiBib

UB Katalog

Ermittle Trefferzahl…

Artikel & mehr
312 Treffer

312 Treffer

Detailansicht für Treffer 41 öffnen

Yaoya Tech Shanghai Files Chinese Patent Application for Preparation and Application of Btk Inhibitor Pyridino-Heterocyclic Compound.

In: Global IP News: Chemical Patent News, 2023-04-12

Zeitungsartikel

Wie komme ich dran?
Detailansicht für Treffer 42 öffnen

First Affiliated Hospital of Nanchang University Researchers Provide New Study Findings on Kinase Inhibitors (Data mining and safety analysis of BTK inhibitors: A pharmacovigilance investigation based on the FAERS database).(Bruton's tyrosine kinase )

In: Obesity, Fitness & Wellness Week, 2022-12-03, S. 1721-1721

serialPeriodical

Wie komme ich dran?
Detailansicht für Treffer 43 öffnen

New Pharmacology Study Results from Sun Yat-sen University Described [Design, synthesis and evaluation of a series of potential prodrugs of a Bruton's tyrosine kinase (BTK) inhibitor].

In: Health & Medicine Week, 2023-03-24, S. 3783

Zeitungsartikel

Wie komme ich dran?
Detailansicht für Treffer 44 öffnen

New Medicinal Chemistry Findings from Tsinghua University Described (Design, Synthesis, and Evaluation of Btk-targeting Protacs With Optimized Bioavailability In Vitro and In Vivo).

In: Health & Medicine Week, 2023-08-11, S. 3332

Zeitungsartikel

Wie komme ich dran?
Detailansicht für Treffer 45 öffnen

Patent Issued for Treatment of B cell cancers using a combination comprising Btk inhibitors (USPTO 11701357).

In: Health & Medicine Week, 2023-08-11, S. 9208

Zeitungsartikel

Wie komme ich dran?
Detailansicht für Treffer 46 öffnen

Identification of four novel mutations in BTK from six Chinese families with X-linked agammaglobulinemia.

Zhou, Q ; Teng, Y ; et al.

In: Clinica chimica acta; international journal of clinical chemistry, Jg. 531 (2022-06-01), S. 48-55

academicJournal

Wie komme ich dran?
Detailansicht für Treffer 47 öffnen

Chengdu Jiabao Medicine Silver Medicine Tech Submits Patent Application for Pyrazolopyridines as Selective BTK Kinase Inhibitors.

In: Global IP News: Biotechnology Patent News, 2023-01-13

Zeitungsartikel

Wie komme ich dran?
Detailansicht für Treffer 48 öffnen

Study Results from Chengdu University of Traditional Chinese Medicine Provide New Insights into Acute Lung Injury (Ibrutinib Prevents Acute Lung Injury via Multi-Targeting BTK, FLT3 and EGFR in Mice).

In: Health & Medicine Week, 2022-12-02, S. 7238

Zeitungsartikel

Wie komme ich dran?
Detailansicht für Treffer 49 öffnen

Anhui Provincial Cancer Hospital Registers Clinical Trial to Study Orelabrutinib in Combination with Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated with BTK Inhibitors.

In: Contify Life Science News, 2022-12-08

Zeitungsartikel

Wie komme ich dran?
Detailansicht für Treffer 50 öffnen

ASH 2022 | Ascentage Pharma to Present Initial Data of Bcl-2 Inhibitor Lisaftoclax (APG-2575) in Combination with BTK Inhibitors for the Treatment of R/R CLL/SLL, Including an ORR of 98%, in an Oral Report at the ASH Annual Meeting.

In: PR Newswire, 2022-11-03

Zeitungsartikel

Wie komme ich dran?
Detailansicht für Treffer 51 öffnen

BeiGene Expands Reach of its Innovative BTK Inhibitor with Recent Regulatory Approvals in Latin America.

In: Business Wire, 2022-10-26

Zeitungsartikel

Wie komme ich dran?
Detailansicht für Treffer 52 öffnen

Studies from Hebei Medical University Further Understanding of Neuromyelitis Optica (Changes In the Btk/nf-kappa B Signaling Pathway and Related Cytokines In Different Stages of Neuromyelitis Optica Spectrum Disorders).

In: Health & Medicine Week, 2022-07-22, S. 6296

unknown

Wie komme ich dran?
Detailansicht für Treffer 53 öffnen

New Study Findings from First Affiliated Hospital of Soochow University Illuminate Research in Clinical Trials and Studies (Phase 1 dose escalation study of MH048, a novel and non-covalent BTK inhibitor in patients with relapsed or refractory ...)

In: Health & Medicine Week, 2022-06-24, S. 3844

Zeitungsartikel

Wie komme ich dran?
Detailansicht für Treffer 54 öffnen

Patent Issued for Substituted nicotinimide inhibitors of BTK and their preparation and use in the treatment of cancer, inflammation and autoimmune disease (USPTO 11345695).

In: Health & Medicine Week, 2022-06-24, S. 9020

Zeitungsartikel

Wie komme ich dran?
Detailansicht für Treffer 55 öffnen

Sichuan Haisco Pharmaceutical Applies for Patent on BTK Inhibitor Ring Derivative as Well as Preparation Method and Pharmaceutical Application Thereof.

In: Global IP News: Pharmaceutical Patent News, 2022-09-28

Zeitungsartikel

Wie komme ich dran?
Detailansicht für Treffer 56 öffnen

Everest Medicines Receives Approval of Investigational New Drug Application from China NMPA for EVER001, a Novel BTK Inhibitor in Development for Treatment of Renal Diseases.

In: Plus Company Updates, 2022-09-27

Zeitungsartikel

Wie komme ich dran?
Detailansicht für Treffer 57 öffnen

Everest Medicines Receives Approval of Investigational New Drug Application from China NMPA for EVER001, a Novel BTK Inhibitor in Development for Treatment of Renal Diseases.

In: Contify Life Science News, 2022-09-26

Zeitungsartikel

Wie komme ich dran?
Detailansicht für Treffer 58 öffnen

Everest Medicines Receives Approval of Investigational New Drug Application from China NMPA for EVER001, a Novel BTK Inhibitor in Development for Treatment of Renal Diseases.

In: PR Newswire, 2022-09-25

Zeitungsartikel

Wie komme ich dran?
Detailansicht für Treffer 59 öffnen

Guangzhou Lupeng Pharmaceutical Submits Chinese Patent Application for Inhibitor of BTK and Mutants Thereof.

In: Global IP News: Pharmaceutical Patent News, 2022-09-10

Zeitungsartikel

Wie komme ich dran?
Detailansicht für Treffer 60 öffnen

LIMES Randomised Controlled Trial about Sirolimus Coated Balloon in BTK takes the first Stride: patient enrolment started.

In: CNW Group, 2022-07-29

Zeitungsartikel

Wie komme ich dran?

xs 0 - 576

sm 576 - 768

md 768 - 992

lg 992 - 1200

xl 1200 - 1366

xxl 1366 -